Exploring the role of new biomarkers in predicting the efficacy of peritoneal dialysis: an observing cohort study

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027473

Enrollment

Unknown

Registered

2019-11-14

Start date

2020-01-01

Completion date

Unknown

Last updated

2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage renal disease/Peritoneal diallysis

Interventions

High transport rate group:N/A

Low transport rate group:N/A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years. 2. ESRD patents who receives peritoneal dialysis catheterization in the department of nephrology, West China Hospital of Sichuan University. 3. The patents can be evaluated routinely as required.

Exclusion criteria

Exclusion criteria: 1. Peritonitis occurred before or during the first PET. 2. Patients experienced kidney transplantation or maintenance hemodialysis previously. 3. Malignant tumors occurred before peritoneal dialysis or during follow-up period.

Design outcomes

Primary

Measure	Time frame
peritoneal transport function;copeptin;Chemerin;sST2;	—

Secondary

Measure	Time frame
Residual renal function;sICAM-1;VEGF;AQP1;CA125;	—

Countries

China

Contacts

Public ContactLi Zi

West China Hospital of Sichuan University

lizihx@163.com+86 18980601212

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026